Gencell Ltd
Tel Aviv Stock ExchangeTotal Valuation
Gencell Ltd carries a market capitalization of 21.10M, placing it among publicly traded companies globally. Its enterprise value stands at 26.63B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 21.10M |
| Enterprise Value | 26.63B |
Share Statistics
Gencell Ltd currently has 108.16M shares outstanding.
| Shares Outstanding | 108.16M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 3,597.90, and the price-to-book ratio stands at -95.05.
| PE Ratio | N/A |
| PS Ratio | 3,597.90 |
| PB Ratio | -95.05 |
| P/TBV Ratio | 397.94 |
| P/FCF Ratio | -1,859.75 |
| P/OCF Ratio | -1,221.86 |
Enterprise Valuation
| EV / Sales | 3,597.56 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Financial Position
Gencell Ltd maintains a current ratio of 7.32, meaning it holds 7.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 12.02, indicating elevated leverage, while an interest coverage ratio of -175.50 demonstrates limited ability to service its debt obligations.
| Current Ratio | 7.32 |
| Quick Ratio | 1.11 |
| Debt / Equity | 12.02 |
| Debt / EBITDA | -0.37 |
| Interest Coverage | -175.50 |
Financial Efficiency
| Return on Equity (ROE) | -106.01 |
| Return on Assets (ROA) | -44.56 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 4.33 |
Taxes
| Income Tax | 191,000.00 |
| Effective Tax Rate | N/A |
Stock Price Statistics
Gencell Ltd's stock has declined approximately -29.92593% over the past 52 weeks. The 50-day moving average sits at 96.69, while the 200-day moving average is 115.07.
| Beta (5Y) | N/A |
| 52-Week Price Change | -29.92593% |
| 50-Day Moving Average | 96.69 |
| 200-Day Moving Average | 115.07 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Gencell Ltd generated 7.40M in revenue and converted that into -36.68M in net income, yielding earnings per share of -0.34. EBITDA reached -21.94M, while operating income came in at -21.94M.
| Revenue | 7.40M |
| Gross Profit | -2.65M |
| Operating Income | -21.94M |
| Pretax Income | -36.48M |
| Net Income | -36.68M |
| EBITDA | -21.94M |
| EBIT | -21.94M |
| Earnings Per Share (EPS) | -0.34 |
Balance Sheet
Gencell Ltd holds 10.57M in cash and equivalents against 8.04M in total debt, resulting in a net debt position of -10.57M. Total book value stands at -280.21M, with working capital of 60.38M providing operational flexibility.
| Cash & Cash Equivalents | 10.57M |
| Total Debt | 8.04M |
| Net Debt | -10.57M |
| Equity (Book Value) | -280.21M |
| Book Value Per Share | -2.61 |
| Working Capital | 60.38M |
Cash Flow
Gencell Ltd produced -21.80M in operating cash flow over the past twelve months. After subtracting -7.48M in capital expenditures, free cash flow totaled -29.28M - equivalent to -0.27 per share.
| Operating Cash Flow | -21.80M |
| Capital Expenditures | -7.48M |
| Free Cash Flow | -29.28M |
| FCF Per Share | -0.27 |
Margins
Gencell Ltd operates with a gross margin of -35.81, reflecting its pricing power and cost economics. The operating margin of -296.34 and net profit margin of -495.42 provide insight into operational efficiency.
| Gross Margin | -35.81 |
| Operating Margin | -296.34 |
| Pretax Margin | -492.84 |
| Profit Margin | -495.42 |
| EBITDA Margin | -296.34 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -0.12 |
| FCF Yield | -0.05 |
Stock Splits
Gencell Ltd's most recent stock split took place on October 19, 2025 with a 5:1 split ratio.
| Last Split Date | 10/19/2025 |
| Split Ratio | 5:1 |
Scores
Gencell Ltd posts an Altman Z-Score of 933.05, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 933.05 |